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Use of hospitals, physician visits, and hospice care during last
six months of life among cohorts loyal to highly respected hospitals
in the United States
John E Wennberg, Elliott S Fisher, Thérèse A Stukel, Jonathan S Skinner, Sandra M Sharp, Kristen K Bronner
Abstract
Objective To evaluate the use of healthcare resources during
the last six months of life among patients of US hospitals with
strong reputations for high quality care in managing chronic
illness.
Design Retrospective cohort study based on claims data from
the US Medicare programme.
Participants Cohorts receiving most of their hospital care from
77 hospitals that appeared on the 2001 US News and World
Report “best hospitals” list for heart and pulmonary disease,
cancer, and geriatric services.
Main outcome measures Use of healthcare resources in the
last six months of life: number of days spent in hospital and in
intensive care units; number of physician visits; percentage of
patients seeing 10 or more physicians; percentage enrolled in
hospice. Terminal care: percentage of deaths occurring in
hospital; percentage of deaths occurring in association with a
stay in an intensive care unit.
Results Extensive variation in each measure existed among the
77 hospital cohorts. Days in hospital per decedent ranged from
9.4 to 27.1 (interquartile range 11.6-16.1); days in intensive care
units ranged from 1.6 to 9.5 (2.6-4.5); number of physician visits
ranged from 17.6 to 76.2 (25.5-39.5); percentage of patients
seeing 10 or more physicians ranged from 16.9% to 58.5%
(29.4-43.4%); and hospice enrolment ranged from 10.8% to
43.8% (22.0-32.0%). The percentage of deaths occurring in
hospital ranged from 15.9% to 55.6% (35.4-43.1%), and the
percentage of deaths associated with a stay in intensive care
ranged from 8.4% to 36.8% (20.2-27.1%).
Conclusion Striking variation exists in the utilisation of end of
life care among US medical centres with strong national
reputations for clinical care.
Introduction
The frequency of use of hospitals, intensive care units, and physi-
cian visits among patients with chronic illness varies extensively
across hospital regions in the United States, including regions
served by well known academic medical centres. The variations
are unrelated to population based measures of need but are
closely associated with the per capita supply of hospital beds and
physicians.1–4 The variations in frequency of use of these “supply
sensitive” services during the last six months of life are
particularly striking.1 These variations are of concern because
they do not seem to reflect patients’ preferences or rates of
illness. Moreover, patients with chronic illnesses who live in
regions with high rates of use do not seem to have better health
outcomes.5–7 For these reasons, we have argued that the research
agenda for academic medical centres should give high priority to
comparative studies of their own patterns of practice with the
goal of rationalising the management of chronically ill patients
and answering questions about how many hospital beds and
physicians are needed to provide optimal care.5 8 An important
first step is to obtain population based performance measures
specific to academic medical centres. In this paper, we document
extensive variations in end of life care among cohorts of patients
enrolled in Medicare who receive most of their inpatient care at
well known academic medical centres in the United States.
Methods
Selection of cohorts
Hospital specific utilisation measures are feasible because
patients, particularly those with chronic illness, tend to receive
most of their inpatient care from a given hospital.4 For this study,
we identified those patients who received most of their inpatient
care during the last two years of their lives from a hospital that
appeared on the 2001 US News and World Report list of “Ameri-
ca’s best hospitals” for geriatric care and for the treatment of
three common chronic illnesses: heart disease, cancer, and
pulmonary disease.9 By using Medicare’s hospital admission files
for all Medicare patients who died in 1999-2000, we assigned
decedents to the hospital used most often during the last two
years of life. In the case of a tie, assignment was to the last hospi-
tal used before death. We included only decedents who had been
continuously enrolled in traditional Medicare during that
period. We generated utilisation measures for the cohorts
assigned to the selected hospitals. The databases used to
generate performance measures included a 100% sample of
hospital admissions and hospice enrolments and a 20% sample
of claims from physicians and laboratories.
Outcome measures
The measures of utilisation during the last six months of life
included the number of days spent in hospital (“hospital days”),
the number of days spent in intensive care units (“ICU days”), the
number of physician visits, the percentage of patients seeing 10
or more physicians, and the percentage of patients enrolled in a
hospice. Measures of intensity of terminal care included the per-
centage of deaths occurring in hospital and the percentage of
deaths involving a stay in an intensive care unit.
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Statistical analysis
We used Iezzoni’s approach to coding chronic conditions.10 On
the basis of diagnoses that appeared on the record of the last
hospital admission, we determined the presence of up to 11
chronic conditions and used these conditions to adjust for differ-
ences among cohorts in underlying rates of disease. The
denominator for calculating utilisation rates in the last six
months of life was the full six months of observation before
death. We calculated crude hospital specific rates by using the
number of cohort members assigned to the hospital as the
denominator.
In this paper, we have adjusted the hospital and visit rates
directly for age, sex, race, and illness by using overdispersed
Poisson regression models.11 In the regression models, the
dependent variable was the total event count per decedent and
the independent variables were indicator variables for the study
hospitals and for age (five categories), sex, race (non-black, black),
and chronic condition (11 dichotomous variables). We centred
all covariates about the population mean so that the rates reflect
an average member of the study population. As patients were
nested within hospitals, we used the overdispersion parameter to
adjust the confidence intervals for correlations among outcomes
of patients within the same cohort. We used overdispersed logis-
tic regression to analyse events that could occur only once (for
example, enrolment in a hospice). To transform the hospital spe-
cific regression coefficients into a directly standardised rate on
the original scale, we exponentiated and calibrated them so that
they had the same overall mean as the crude hospital specific
rates.
We evaluated relations between hospital specific rates by
using product-moment correlation. We used the coefficient of
variation and interquartile and extremal range ratios to compare
the degree of variation among utilisation measures. We also
compared variation graphically by displaying the directly stand-
ardised rate for each hospital, expressed as a ratio to the mean
rate among the 77 hospital cohorts.
Final sample of hospital specific cohorts
Ninety two acute general hospitals appeared one or more times
on the US News and World Report list for 2001. We excluded hos-
pitals with fewer than 100 decedents with data for physician
claims, leaving 77 hospital cohorts. In keeping with the
principles of population based epidemiology, performance
measures reflect the total amount of care received, regardless of
where or by whom care was provided. However, as patient loyalty
(defined as percentage of all days in hospital that occurred in the
assigned hospital) tended to be strong, the measures primarily
reflect services undertaken by providers affiliated with the medi-
cal centre to which the patients were assigned. Among the 77
hospital specific cohorts, patient loyalty, measured over the two
years before death, ranged from 64.6% to 91.9%, with a median
of 82.5% and a mean of 81.4%.
Results
Table 1 shows the characteristics of the study population. Of the
115 089 patients, 98 415 (85%) were chronically ill, many with
two or more conditions. The intensity of care during the last six
months of life and at the time of death varied substantially. The
figure shows the standardised utilisation ratios and statistical
measures of variation among the 77 hospital cohorts. Among
the 77 hospital cohorts, the average number of days spent in
hospital during the last six months of life was more than 27
days—almost a month—in the highest ranked cohort and fewer
than 10 days in the lowest ranked cohort. Average ICU days var-
ied by a factor of six, from 1.6 to 9.5 days per person; physician
visits varied by a factor of four, from less than 18 to more than 76
visits per decedent. The propensity to use multiple physicians
varied from less than 17% of patients seeing 10 or more
physicians in the last six months of life to more than 58% of
patients. The percentage of deaths occurring in hospital ranged
from less than 16% to more than 55%; deaths associated with a
stay in an intensive care unit varied from less than 9% to more
than 36%. Enrolment in a hospice varied among the cohorts
from less than 11% of decedents to more than 43%.
Table 2 examines the intensity of care during the last six
months for cohorts loyal to major teaching hospitals located in
metropolitan regions with two or more major teaching hospitals.
They are ranked according to the (unweighted) average number
of patient days per decedent. By this measure, the hospitals
located in Manhattan provided the most care. Other regions with
high hospital day rates included Los Angeles, Philadelphia, and
Washington, DC. Patient cohorts loyal to the teaching hospitals
in these regions also tended to have a higher frequency of physi-
cian visits, and a higher proportion saw 10 or more physicians.
However, the use of intensive care units varied: the rates were
high among the listed teaching hospital cohorts in Los Angeles,
low in Washington, DC, and varied substantially according to
specific hospital cohorts in Philadelphia and New York. Cohorts
in Boston and St Louis exhibited considerable within area varia-
tion in hospital days and ICU days. By contrast, those in Minne-
apolis and San Francisco had low rates on all four measures of
intensity of care in the last six months of life.
The observed variation could have been generated by substi-
tution between hospital use, physician visits, and hospice care.
Enrolment in a hospice was inversely correlated with hospital
Table 1 Illness and demographic characteristics among patients assigned to
77 hospital cohorts. Values are numbers (percentages)
Characteristic Patients (n=115 089)
Chronic conditions:
Cancer: solid tumours 31 764 (27.6)
Lymphomas and leukaemias 6 279 (5.5)
AIDS 103 (0.1)
Chronic pulmonary disease 25 864 (22.5)
Coronary artery disease 9 931 (8.6)
Congestive heart failure 37 584 (32.7)
Peripheral vascular disease 5 958 (5.2)
Severe chronic liver disease 2 317 (2.0)
Diabetes with end organ damage 2 902 (2.5)
Chronic renal failure 6 809 (5.9)
Nutritional deficiencies 12 068 (10.5)
Dementia 17 062 (14.8)
Functional impairment 3 040 (2.6)
No of chronic conditions:
None 17 674 (15.4)
1 only 49 568 (43.1)
2 only 33 914 (29.5)
3 only 11 656 (10.1)
≥4 2 277 (2.0)
Demographic characteristics:
Age 65-69 12 912 (11.2)
Age 70-74 19 811 (17.2)
Age 75-79 23 545 (20.5)
Age 80-84 22 995 (20.0)
Age ≥85 35 826 (31.1)
Male 52 313 (45.5)
Female 62 776 (54.5)
Non-black 97 740 (84.9)
Black 17 349 (15.1)
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days in the last six months of life (r = − 0.41; P < 0.0002), the
chance of dying in a hospital (r = − 0.51; P < 0.0001), and the
percentage of deaths occurring in association with a stay in the
intensive care unit (r = − 0.28; P = 0.012). However, the percent-
age enrolled in a hospice was not correlated significantly
(P > 0.05) with fewer physician visits, seeing 10 or more
physicians, or ICU days in the last six months of life. We found a
strong positive correlation between the number of days spent in
hospital and the number of physician visits within the last six
months of life (r = 0.77; P < 0.0001).
Discussion
Academic medical centres in the United States with reputations
for excellence differed dramatically in the care they provided to
patients during the last six months of life. For example, patient
cohorts loyal to the University of California Medical Center in
San Francisco had, on average, 27 physician visits, with 30% see-
ing 10 or more physicians and spending an average of 11.5 days
in hospital. For the New York University hospital cohort, average
physician visits were 76, nearly triple the frequency in San Fran-
cisco, with 57% seeing 10 or more physicians and spending an
average of 27.1 days in hospital. The context of terminal care also
varied. For example, the chance that death was associated with a
stay in an intensive care unit was 1.84 times greater for patients
loyal to Cedars-Sinai Hospital in Los Angeles (36.8%) than for
patients loyal to New York’s Mt Sinai Hospital (21.1%).
What explains such variation?
Among regions, a direct relation exists between supply and utili-
sation of services. The frequency of use of physician services is
strongly associated with the local workforce supply,1 12 13 and bed
supply “explains” more than half of the variation in hospital
admission rates for medical conditions.1 The effect of bed supply
is to influence the threshold for admitting patients with chronic
illnesses such as congestive heart failure, chronic pulmonary
obstructive disease, and cancer.2–4 14 Finally, physicians have been
shown to adapt their decisions about admission and discharge to
the availability of intensive care unit beds, admitting more
patients with lower severity of illness and extending their length
of stay when more beds are available.15 16 In the light of this evi-
dence, the likely explanation for the variations in acute hospital
care and physician visits is variation in bed and workforce capac-
ity relative to the size of population loyal to the 77 hospitals.
The key question is whether greater frequency of physician
visits and hospital care for chronically ill patients (many of whom
are in the sample of decedents) results in better health outcomes.
Using a variety of measures, two randomised trials of elderly
patients from the US Veterans Affairs healthcare system found
that more frequent office visits and more intensive primary care
were associated with increased use of the hospital but no
improvement in health or function.17 18 Both studies found that
more frequent office based visits were associated with a
non-significant increase in mortality. Recently, we compared
practice patterns and health outcomes across regions of the
United States that were similar in baseline health status but that
differed by 60% in overall utilisation of services.6 Greater
frequency of use was associated with worse outcomes: quality
and access to care were slightly worse in higher spending
regions, and mortality was between 2% and 5% higher, suggest-
ing that overuse of supply sensitive services was leading to harm,
possibly because greater use of hospital and specialist care
exposes populations to greater risks of medical errors.7
Limitations of the study
Our study has limitations. Firstly, the focus was on acute hospital
care and frequency of physician visits. With the exception of
hospice care, we were unable to evaluate the contribution of
community care services such as home health agencies or nurs-
ing homes. Interestingly, whereas hospice enrolment varied sub-
stantially among the 77 cohorts, we did not find that increased
use of hospice led to less use of intensive care units or physician
visits during the last six months of life. It was, however, associated
with fewer deaths in hospital and, to a lesser degree, with a
decrease in the chance that death was associated with a stay in an
intensive care unit. We had no information on patients’ or
caregivers’ preferences for end of life care or on their satisfaction
with the services provided, the effectiveness of pain control, or
the degree of emotional or physical support provided by each
healthcare system. However, the SUPPORT study documented
deficiencies in these aspects of care across five major medical
centres (two of which were included in our study) and showed
that the differences in hospital care were due neither to case mix
nor to patients’ preferences.19 Indeed, patients’ stated preferences
to avoid deaths in hospital were commonly unfulfilled, whereas
the local bed supply was correlated with probability of dying in
the hospital.
Secondly, the “follow back” design means that we excluded
patients who did not experience at least one hospital admission
during their last two years of life. Among the 306 hospital refer-
ral regions in the Dartmouth Atlas of Health Care, the percentage
of deaths in 1999-2000 without any hospital admission within
two years of death (and hence unassigned to any hospital)
ranged from 8% to 30%. Thus, we based end of life hospital
admission rates on a denominator that is too small. Assuming
that the unassigned deaths in the region are assigned in
proportion to the total number of deaths at each hospital would
suggest adjustment of each end of life variable by 1/(1 − x), where
x is the fraction of “unassigned” deaths. Adjusting our variables














Care during last six months of life Terminal care
14.5Mean 3.72 34.1 37.3 26.9 39.6 23.1
1.38Interquartile
ratio
1.72 1.55 1.47 1.46 1.22 1.34
2.89Extremal
ratio
5.85 4.33 3.46 4.05 3.50 4.38
0.23Coefficient
of variation
























































Distribution of rates and statistical measures of variation for end of life care
among 77 cohorts assigned to hospitals with national reputations for high
quality. ICU=intensive care unit
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to increase rather than decrease dispersion across hospitals.
Thirdly, we have underestimated loyalty for medical centres that
use affiliated hospitals, because information on affiliation was
not available.
Generalisability
Variations in end of life care among the best hospitals in the
United States raise questions about the appropriate role for
acute hospital care in the management of chronically ill patients.
Patterns of practice during this period of care are highly
correlated with variation at other stages in the progression of
chronic illness. Thus end of life measures provide a good indica-
tor of how hospitals are treating all patients with chronic illness,
not just those near death.6 Typically, hospital level comparisons
are confounded by differences in case mix across communities.
However, all patients in the last six months of life are quite simi-
lar with regard to at least one critical case mix adjuster—they are
all dead within six months. This allows comparisons of use of
hospitals during this period of life, with confidence that regional
differences in illness are not an important cause of the variations
seen. Although we have found that regions allocating the least
resources to patients at the end of life tend to have lower
mortality and do better on other measures of quality for all of
their patients,7 this association needs to be tested in countries
where the frequency of acute hospital care and physician visits is
less than in the United States. We hope the international
research community will focus on learning how to manage
chronic illness better and how to provide end of life care deter-
mined by the needs and wants of patients and not the capacity of
the acute care system.20
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Table 2 Age, sex, race, and illness adjusted rates (95% confidence intervals) for hospital days, days in intensive care, and physician visits and percentage
seeing 10 or more physicians during last six months of life among patient cohorts loyal to selected academic medical centres by region of location
Hospital by region* Hospital days per decedent ICU days per decedent Physician visits per decedent % seeing ≥10 physicians
New York (23.8)
Mount Sinai Hospital 22.8 (22.1 to 23.5) 2.8 (2.6 to 3.0) 53.9 (50.6 to 57.4) 58.5 (51.8 to 66.0)
New York Presbyterian Hospital 21.6 (21.0 to 22.2) 4.5 (4.2 to 4.7) 40.3 (37.9 to 42.8) 37.7 (33.2 to 42.7)
NYU Medical Center-University
Hospital
27.1 (26.1 to 28.1) 6.7 (6.4 to 7.2) 76.2 (71.3 to 81.3) 57.1 (49.0 to 66.4)
Los Angeles (18.7)
UCLA Medical Center 16.1 (15.2 to 17.1) 9.2 (8.6 to 9.8) 43.9 (39.7 to 48.5) 50.9 (42.2 to 61.4)
Cedars-Sinai Medical Center 21.3 (20.6 to 22.0) 7.0 (6.7 to 7.4) 66.2 (62.7 to 69.9) 48.2 (42.5 to 54.8)
Washington, DC (18.4)
Georgetown University Hospital 18.5 (17.3 to 19.8) 3.6 (3.1 to 4.1) 43.0 (37.2 to 49.7) 55.1 (42.6 to 71.3)
Washington Hospital Center 18.2 (17.4 to 19.0) 3.0 (2.7 to 3.2) 37.0 (33.5 to 40.9) 39.4 (32.5 to 47.9)
Philadelphia (18.3)
Hospital of the University of
Pennsylvania
17.2 (16.2 to 18.2) 3.8 (3.4 to 4.2) 40.3 (35.7 to 45.5) 44.7 (35.4 to 56.4)
Thomas Jefferson University
Hospital
19.4 (18.6 to 20.2) 9.5 (9.1 to 10.0) 55.0 (50.8 to 59.4) 53.7 (45.8 to 62.8)
Baltimore (16.3)
Johns Hopkins Hospital 16.1 (15.2 to 17.0) 3.2 (2.9 to 3.5) 28.1 (24.9 to 31.7) 36.7 (29.6 to 45.4)
Francis Scott Key Medical Center 16.5 (15.7 to 17.5) 5.7 (5.3 to 6.1) 23.0 (20.0 to 26.5) 29.4 (22.9 to 37.9)
Chicago (16.1)
University of Chicago Hospital 13.4 (12.6 to 14.3) 3.5 (3.2 to 3.9) 30.2 (26.6 to 34.3) 41.7 (33.5 to 51.9)
Rush-Presbyterian-St Luke’s Medical
Center
17.9 (16.9 to 19.0) 4.5 (4.1 to 4.9) 48.9 (44.1 to 54.3) 35.1 (27.4 to 44.9)
Northwestern Memorial Hospital 17.1 (16.3 to 17.9) 3.5 (3.2 to 3.8) 34.9 (31.7 to 38.4) 40.4 (33.8 to 48.3)
Boston (14.5)
Boston Medical Center 15.6 (14.5 to 16.8) 3.9 (3.5 to 4.4) 31.5 (27.0 to 36.6) 47.8 (37.2 to 61.4)
Massachusetts General Hospital 16.5 (15.8 to 17.1) 2.5 (2.3 to 2.7) 38.8 (35.8 to 41.9) 46.2 (40.0 to 53.3)
Beth Israel Deaconess Medical
Center
12.2 (11.6 to 12.8) 2.4 (2.2 to 2.6) 29.2 (26.5 to 32.2) 34.3 (28.7 to 41.1)
Brigham and Womens Hospital 13.9 (13.1 to 14.7) 3.2 (2.9 to 3.6) 31.9 (28.3 to 36.0) 43.7 (35.6 to 53.6)
St Louis (14.5)
Barnes-Jewish Hospital 16.1 (15.6 to 16.7) 4.4 (4.2 to 4.7) 29.5 (27.3 to 31.9) 30.9 (26.5 to 36.0)
St Louis University Hospital 12.9 (12.0 to 13.9) 6.1 (5.6 to 6.7) 31.5 (27.0 to 36.7) 38.1 (28.7 to 50.4)
Cleveland (13.0)
University Hospitals of Cleveland 12.5 (11.9 to 13.2) 2.4 (2.2 to 2.6) 26.0 (23.3 to 29.0) 30.5 (25.0 to 37.4)
Cleveland Clinic 13.4 (12.8 to 14.1) 3.0 (2.8 to 3.3) 30.9 (28.2 to 33.9) 45.9 (39.5 to 53.4)
Minneapolis (11.4)
Hennepin County Medical Center 9.6 (8.7 to 10.6) 4.0 (3.6 to 4.5) 18.1 (14.7 to 22.4) 28.3 (20.1 to 39.8)
Fairview-University Medical Center 13.3 (12.3 to 14.4) 2.3 (1.9 to 2.6) 23.9 (20.0 to 28.6) 34.8 (25.8 to 46.9)
San Francisco/Bay Area (10.8)
University of CA San Francisco
Medical Center
11.5 (10.6 to 12.4) 2.6 (2.3 to 3.0) 27.2 (23.0 to 32.2) 30.3 (22.0 to 41.9)
Stanford University Hospital 10.1 (9.4 to 10.9) 4.3 (4.0 to 4.7) 22.6 (19.4 to 26.3) 23.1 (17.1 to 31.3)
ICU=intensive care unit.
*Regions ranked by unweighted average for patient days among listed hospital cohorts; average given in parenthesis.
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What is already known on this topic
Population based rates of use of hospitals, intensive care
units, and physician visits vary extensively across US
regions, particularly during the last six months of life
Population based rates are uncorrelated with illness and
patients’ preferences but are closely associated with the
supply of hospital beds and physicians
The outcomes of care are no better among the cohorts of
patients with chronic illness who receive care in regions
with higher rates of use of services
What this study adds
Population based rates of use of hospitals and physician
services can be measured among populations loyal to
specific hospitals
End of life care varies extensively among patient cohorts who
receive most of their care from well known academic medical
centres, even among those located in the same region
Hospital specific information opens the opportunity for
academic medical centres to participate in studies to
improve the quality and efficiency of care
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